onderzoek Novartis reports positive results from phase III IRIDIUM study of inhaled combination QVM149 in patients with uncontrolled asthma 2 oktober 2019Pharma Biz
onderzoek Novartis phase III PREVENT study of Cosentyx to treat patients with axial spondyloarthritis meets 16-week primary endpoint 19 september 2019Pharma Biz
onderzoek Novartis phase III ASCLEPIOS I & II studies of ofatumumab versus Aubagio to treat relapsing forms MS meets primary endpoints 2 september 2019Pharma Biz
onderzoek AstraZeneca announces positive results from phase III ETHOS trial of triple-combo therapy Breztri Aerosphere to treat COPD 29 augustus 2019Pharma Biz
onderzoek AstraZeneca announces update on phase III NEPTUNE trial of Imfinzi in combo with tremelimumab in stage IV NSCLC 26 augustus 2019Pharma Biz
onderzoek AstraZeneca’s phase III DAPA─HF trial of Farxiga to treat heart failure meets primary endpoint 22 augustus 2019Pharma Biz
